From biology to personalized medicine: Recent knowledge in osteosarcoma.

导出 LinkOut

翻译打印收藏纠错

作者： Audrey,Mohr ^[1] ; Maria Eugenia,Marques Da Costa ^[1] ; Olivia,Fromigue ^[2] ; Baptiste,Audinot ^[1] ; Thierno,Balde ^[1] ; Robin,Droit ^[1] ; Samuel,Abbou ^[3] ; Pierre,Khneisser ^[4] ; Pablo,Berlanga ^[5] ; Esperanza,Perez ^[5] ; Antonin,Marchais ^[1] ; Nathalie,Gaspar ^[6]

作者单位： National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy Institute, Villejuif, France. ^[1] National Institute for Health and Medical Research (INSERM) U981, Gustave Roussy Institute, Villejuif, France. ^[2] National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy Institute, Villejuif, France; Department of Oncology for Children and Adolescents, Gustave Roussy Institute, Villejuif, France. ^[3] Department of medical Biology and Pathology, Gustave Roussy Institute, Villejuif, France. ^[4] Department of Oncology for Children and Adolescents, Gustave Roussy Institute, Villejuif, France. ^[5] National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy Institute, Villejuif, France; Department of Oncology for Children and Adolescents, Gustave Roussy Institute, Villejuif, France. Electronic address: nathalie.gaspar@gustaveroussy.fr. ^[6]

关键词 Epigenetic Genetic Next-generation sequencing Osteosarcoma Personalized medicine Transcriptomic

主题词骨肉瘤(Osteosarcoma);人类(Humans);骨肿瘤(Bone Neoplasms)

DOI 10.1016/j.ejmg.2024.104941

PMID 38677541

发布时间 2024-06-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交